• Research To Practice | Oncology Videos

  • Auteur(s): Dr Neil Love
  • Podcast

Page de couverture de Research To Practice | Oncology Videos

Research To Practice | Oncology Videos

Auteur(s): Dr Neil Love
  • Résumé

  • Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
    Copyright © 2023 Research To Practice. All Rights Reserved.
    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT
Épisodes
  • Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers
    Jun 25 2024

    Featuring perspectives from Dr Robin K (Katie) Kelley, Dr Edward Kim and Prof Arndt Vogel, and moderated by Dr Kelley, including the following topics:

    • Introduction (0:00)
    • Recent Developments in the Management of Early- and Intermediate-Stage Hepatocellular Carcinoma (HCC) — Dr Kim (1:58)
    • First-Line Therapy for Advanced HCC and Biliary Tract Cancers (BTCs) — Prof Vogel (22:24)
    • Integration of Targeted Therapy into the Management of Advanced BTCs — Dr Kelley (42:19)

    CME information and select publications

    Voir plus Voir moins
    1 h et 3 min
  • Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation
    Jun 21 2024

    Featuring perspectives from Dr Jonathan W Goldman, Dr Corey J Langer, Dr Joel W Neal, Dr Zofia Piotrowska, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu, including the following topics:

    • Introduction (0:00)
    • Contemporary Care for Patients with Nonmetastatic Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Dr Langer (2:08)
    • Evolving First-Line Treatment for Metastatic NSCLC with an EGFR Mutation — Dr Goldman (22:37)
    • Biological Rationale for and Emerging Role of Antibody-Drug Conjugates in the Management of NSCLC with an EGFR Mutation — Dr Yu (43:23)
    • Other Emerging Strategies for Relapsed Metastatic NSCLC with an EGFR Mutation — Dr Sabari (1:03:33)
    • Current and Future Management of NSCLC with an EGFR Exon 20 Insertion Mutation — Dr Piotrowska (1:20:15)
    • Management of Toxicities Associated with Available and Emerging Therapies for NSCLC with an EGFR Mutation — Dr Neal (1:38:44)

    CME information and select publications

    Voir plus Voir moins
    2 h
  • Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer
    Jun 20 2024

    Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics:

    • Introduction (0:00)
    • The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21)
    • The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18)
    • Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27)
    • Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40)

    NCPD information and select publications

    Voir plus Voir moins
    2 h et 2 min

Ce que les auditeurs disent de Research To Practice | Oncology Videos

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.